ELC GROUP is a fully-fledged global regulatory partner, working with major pharmaceutical stakeholders for over a decade.

From the development stage through to the implementation of clinical trials, completion of product registration, and successful marketing of the product, ELC GROUP aligns itself as a strategic partner to help pharmaceutical companies achieve their healthcare goals.




MHRA sets its post-Brexit strategic direction08/05/2018

The plan outlines the agency’s strategic direction over the coming 5 years and includes a section on how they plan to ensure a smooth European Union (EU) exit under any scenario. »More

Brexit - Stick or Twist?12/04/2018

The EU Commission is working on overdrive at present to encourage pharma companies to take heed of the looming Brexit deadline. »More


The final countdown: Transition from paper/NeeS to eCTD format submission for all regulatory activities18/09/2017

eCTD is of great interest nowadays for the pharmaceutical industries, as the EMA disposed mandatory use of eCTD format for all submissions before 2019. »More

Latest Infographic

Signal Management +

Signal Management

Flow chart to illustrate the process of signal generation, detection and evaluation

View all resources